Sarah Hartmann
- Oncology top 10%
- Cardiology and Cardiovascular Medicine top 5%
- Pulmonary and Respiratory Medicine
- Immunology
- Molecular Biology
- Co-authors
- Zsófia D. DrobniTomas G. NeilanHannah GilmanAmna ZafarDaniel A. ZlotoffRaza M. AlviJingyi GongKerry L. Reynolds
- Topics
- Cancer Immunotherapy and Biomarkers (4 papers)Cardiac tumors and thrombi (3 papers)Neuroendocrine Tumor Research Advances (2 papers)
- Partner nations
- HungaryUnited StatesGermany
In The Last Decade
Sarah Hartmann
8 papers receiving 688 citations
Hit Papers
Peers
Comparison fields: 5 of 60
- Oncology 424
- Cardiology and Cardiovascular Medicine 363
- Pulmonary and Respiratory Medicine 132
- Immunology 103
- Molecular Biology 96
Countries citing papers authored by Sarah Hartmann
This map shows the geographic impact of Sarah Hartmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Hartmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Hartmann more than expected).
Fields of papers citing papers by Sarah Hartmann
This network shows the impact of papers produced by Sarah Hartmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Hartmann. The network helps show where Sarah Hartmann may publish in the future.
Co-authorship network of co-authors of Sarah Hartmann
This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Hartmann. A scholar is included among the top collaborators of Sarah Hartmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Hartmann. Sarah Hartmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 97 | |
| 3 | 47 | |
| 4 | 62 | |
| 5 | 58 | |
| 6 | The Impact of Lighting Type on Consumer Behavior in the Purchase of Healthy Products | 0 |
| 7 | 54 | |
| 8 | Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaquebreakdown → | 356 |
| 9 | 8 |
About Sarah Hartmann
Sarah Hartmann is a scholar working on Oncology, Cardiology and Cardiovascular Medicine and Marketing, having authored 9 papers that have together received 696 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Cardiac tumors and thrombi (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (363 citations), Oncology (424 citations) and Internal Medicine (55 citations). Sarah Hartmann has collaborated with scholars based in Hungary, United States and Germany. Frequent co-authors include Zsófia D. Drobni, Tomas G. Neilan, Hannah Gilman, Amna Zafar, Daniel A. Zlotoff, Raza M. Alvi, Jingyi Gong, Kerry L. Reynolds, Ryan J. Sullivan and Leyre Zubiri. Their work appears in journals such as Circulation, PLoS ONE and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.